Nucleic acid medicine

Next generation drugs using DNA and RNA
With research conducted in countries around the world.

Nucleic acid medicines are next generation drugs which use “nucleic acids” such as DNA and RNA. While research are being conducted on nucleic acid medicines in various countries around the world, Bonac has developed “Bonac Nucleic Acid” based on a novel approach.

New nucleic acid medicines developed by Bonac

Bonac Nucleic Acid

Bonac Nucleic Acid is characterized by its unique structure of single-stranded long-chain nucleic acid molecules,
which is different than the previously used siRNA. This structure not only improved stability of the drug in the body, but also enabled avoidance of innate immune response mediated by Toll-like receptor 3 (TLR3). Having overcome the issues associated with the previously used siRNA, Bonac Nucleic Acid is expected to become a new type of nucleic acid medicine.

  • Nucleic acid medicine

ページ上部へ